Association between C-reactive protein to albumin ratio and major adverse cardiac events in patients with stable coronary artery disease treated by percutaneous coronary intervention

C反应蛋白/白蛋白比值与经皮冠状动脉介入治疗的稳定性冠状动脉疾病患者主要不良心脏事件之间的关联

阅读:3

Abstract

OBJECTIVE: The purpose of this study was to explore the connection between the C-reactive protein to albumin ratio (CAR) and major adverse cardiac events (MACE) in individuals with stable coronary artery disease (CAD) who underwent percutaneous coronary intervention (PCI). METHODS: This study employed a retrospective cohort design and involved 196 individuals who had recently been diagnosed with stable CAD and received elective PCI. Participants were categorized into four groups according to their CAR quartiles, with the lowest quartile (Q1) serving as the reference group. The primary endpoint was MACE, which was defined as a combination of all-cause mortality, non-fatal myocardial infarction, and non-fatal stroke. To evaluate the association between CAR and MACE, multivariable Cox regression, Kaplan-Meier survival analysis, and restricted cubic spline analyses were utilized. RESULTS: Among the 196 participants (average age, 72.85 ± 10.11 years), 27 (13.78%) experienced MACE during an average follow-up period of 742 days. The rate of MACE rose significantly across the CAR quartiles (Q1: 8.16%, Q2: 6.12%, Q3: 8.16%, Q4: 32.65%; p < 0.001). In the multivariable analysis, compared to patients in the lowest CAR quartile (Q1), those in the highest quartile (Q4) had a significantly increased risk of MACE (Model 3: HR = 4.87, 95% CI: 1.40-16.95, p = 0.013). A notable nonlinear relationship was observed between CAR and MACE, with an inflection point at 0.030. Analyses of subgroups indicated a persistent association between increased CAR and MACE across all evaluated strata, with no significant interactions found (all P interaction > 0.05). CONCLUSIONS: Among patients with stable CAD who received PCI, a nonlinear association was found between CAR and MACE.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。